96 related articles for article (PubMed ID: 22241371)
41. A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates.
Tsuchiya T; Nagayasu T; Yamasaki N; Matsumoto K; Miyazaki T; Tagawa T; Nakamura A; Minami H; Taniguchi H; Akamine S; Hisano H; Taniguchi Y
Clin Lung Cancer; 2012 Nov; 13(6):464-9. PubMed ID: 22424872
[TBL] [Abstract][Full Text] [Related]
42. [Side effects analyses in consideration of renal function for S-1-administered patients].
Iwai M; Kimura M; Yoshimura T; Yasuda T
Gan To Kagaku Ryoho; 2011 Jun; 38(6):973-6. PubMed ID: 21677489
[TBL] [Abstract][Full Text] [Related]
43. Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604).
Tahara M; Fuse N; Mizusawa J; Sato A; Nihei K; Kanato K; Kato K; Yamazaki K; Muro K; Takaishi H; Boku N; Ohtsu A
Cancer Sci; 2015 Oct; 106(10):1414-20. PubMed ID: 26250827
[TBL] [Abstract][Full Text] [Related]
44. [A Case of Pancreatic Cancer with Multiple Liver Metastases That Developed Postoperatively and Showed a Complete Response with S-1 Monotherapy].
Saso K; Murata M; Asai K; Yamada M; Yagi T; Katsuyama S; Sawami H; Takahashi H; Takayama O; Tanaka N; Baba M; Yamamoto M; Hiratsuka M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1620-2. PubMed ID: 26805116
[TBL] [Abstract][Full Text] [Related]
45. [A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Hashimoto T; Arai K; Iwasaki Y; Saze Z; Takahashi K; Yamaguchi T; Matsumoto H; Yasutome M; Hiruma K; Yamashita Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):985-8. PubMed ID: 16835493
[TBL] [Abstract][Full Text] [Related]
46. Treatment of gastric cancer in Asia: the missing link.
Nishida T
Lancet Oncol; 2009 Nov; 10(11):1027-8. PubMed ID: 19880057
[No Abstract] [Full Text] [Related]
47. [Two patients effectively treated by S-1 monotherapy for metastatic pancreatic cancer].
Ikeda M; Ueno H
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1515-9. PubMed ID: 17033250
[TBL] [Abstract][Full Text] [Related]
48. A case of corneal epithelial lesion and keratoconjunctival pigmentation due to anticancer drug S-1.
Kobashi H; Kamiya K; Shimizu K
Jpn J Ophthalmol; 2011 Mar; 55(2):163-5. PubMed ID: 21400063
[No Abstract] [Full Text] [Related]
49. A case report: pancreatic squamous cell carcinoma with effective response by S-1 therapy.
Ikeda A; Okuno T; Miki I; Yokozaki H; Kutsumi H; Azuma T
Clin J Gastroenterol; 2014 Feb; 7(1):79-83. PubMed ID: 26183513
[TBL] [Abstract][Full Text] [Related]
50. [The clinical effect of combination therapy for oral cancer with S-1, superselective intra-arterial chemotherapy, and radiation therapy].
Yamamoto C; Yoshikawa H; Fukumoto S; Higuchi T; Yoshida M; Horinouchi Y; Uehara S; Yasumori K
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2575-8. PubMed ID: 22189221
[TBL] [Abstract][Full Text] [Related]
51. Safety and feasibility of S-1 adjuvant chemotherapy for pancreatic cancer in elderly patients.
Aoyama T; Katayama Y; Murakawa M; Atsumi Y; Yamaoku K; Kanazawa A; Higuchi A; Shiozawa M; Kobayashi S; Ueno M; Morimoto M; Yamamoto N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
Cancer Chemother Pharmacol; 2015 Jun; 75(6):1115-20. PubMed ID: 25821166
[TBL] [Abstract][Full Text] [Related]
52. Influence of mirtazapine on salivary cortisol in depressed patients.
Laakmann G; Hennig J; Baghai T; Schüle C
Neuropsychobiology; 2003; 47(1):31-6. PubMed ID: 12606843
[TBL] [Abstract][Full Text] [Related]
53. An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma.
Naito S; Tsukamoto T; Usami M; Fujimoto H; Akaza H
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1065-70. PubMed ID: 20157711
[TBL] [Abstract][Full Text] [Related]
54. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
55. [Two cases of advanced gastric cancer completely responding to S-1 neoadjuvant chemotherapy].
Komatsu H; Morimoto J; Yamashita Y; Ikeya T; Yamazoe S; Kodai S; Shimizu S; Yamamoto A; Kanazawa A; Inoue T; Tsukamoto T; Ikehara T; Nishiguchi Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2339-41. PubMed ID: 22202375
[TBL] [Abstract][Full Text] [Related]
56. Mirtazapine for symptom control in refractory gastroparesis.
Malamood M; Roberts A; Kataria R; Parkman HP; Schey R
Drug Des Devel Ther; 2017; 11():1035-1041. PubMed ID: 28408802
[TBL] [Abstract][Full Text] [Related]
57. Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination.
Osugi H; Takada N; Takemura M; Kaseno S; Lee S; Ueno M; Tanaka Y; Fukuhara K; Fujiwara Y; Kinoshita H
Oncol Rep; 2002; 9(4):811-5. PubMed ID: 12066214
[TBL] [Abstract][Full Text] [Related]
58. A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer.
Ikeda M; Ioka T; Ito Y; Yonemoto N; Nagase M; Yamao K; Miyakawa H; Ishii H; Furuse J; Sato K; Sato T; Okusaka T
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):163-9. PubMed ID: 22677367
[TBL] [Abstract][Full Text] [Related]
59. [A Patient with Stage IV Advanced Gastric Cancer with Multiple Liver Metastases Living for More Than 6 Years after Treatment with TS-1 Alone].
Hara R; Yoshida K; Fujii T; Ikeda A; Hashiyata H; Nakamoto K; Takeshige M
Gan To Kagaku Ryoho; 2016 Jul; 43(7):893-5. PubMed ID: 27431636
[TBL] [Abstract][Full Text] [Related]
60. [Effectiveness of mirtazapine for digestive symptoms in palliative care - retrospective study of 50 cases].
Shibahara H; Uematsu N; Imai E; Tokura Y; Nishimura D
Gan To Kagaku Ryoho; 2014 Mar; 41(3):329-33. PubMed ID: 24743278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
